Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cytomegalovirus Infection

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    June 2021
  1. LIU XB, Liu H, Liu J, Cheung AKL, et al
    Cytomegalovirus Latency Exacerbated small-for-size Liver Graft Injury through Activation of CCL19/CCR7 in Hepatic Stellate Cells.
    Transplantation. 2021 Jun 2. doi: 10.1097/TP.0000000000003846.
    PubMed     Abstract available


    March 2021
  2. DAVID E, Zhu M, Bennett BC, Cheng D, et al
    Undernutrition and Hypoleptinemia Modulate Alloimmunity and CMV-specific Viral Immunity in Transplantation.
    Transplantation. 2021 Mar 10. pii: 00007890-900000000-95315.
    PubMed     Abstract available


    December 2020
  3. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Association of HHV-6 With Outcomes in CMV-Seronegative Liver Transplant Recipients With CMV-Seropositive Donors Receiving Preemptive Antiviral Therapy.
    Transplantation. 2020 Dec 29. pii: 00007890-900000000-95428.
    PubMed     Abstract available


    November 2020
  4. COOK CH
    Cytomegalovirus: Another Source of Antibody Mediated Graft Injury?
    Transplantation. 2020 Nov 18. doi: 10.1097/TP.0000000000003549.
    PubMed    


  5. SAUNDERS U, Li M, Boddeda SR, Maher S, et al
    Murine Cytomegalovirus-Induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection.
    Transplantation. 2020 Nov 18. doi: 10.1097/TP.0000000000003548.
    PubMed     Abstract available


    September 2020
  6. ROBAK O, Kastner MT, Stecher C, Schneider M, et al
    Cytomegalovirus Infection Downregulates Vitamin-D Receptor in Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Transplantation. 2020 Sep 2. doi: 10.1097/TP.0000000000003448.
    PubMed     Abstract available


    August 2020
  7. KRONIG I, Elkrief L, Berney T, Van Delden C, et al
    Combination Treatment With Letermovir and Ganciclovir for Maintenance Therapy of Multidrug-resistant CMV Infection in a Liver Transplant Recipient.
    Transplantation. 2020;104:e248-e249.
    PubMed    


    February 2020
  8. PHOOMPOUNG P, Ferreira VH, Tikkanen J, Husain S, et al
    Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients.
    Transplantation. 2020;104:404-409.
    PubMed     Abstract available


  9. KOTTON CN
    A Fine Balance: Using Letermovir for Salvage Antiviral Treatment While Preserving Efficacy.
    Transplantation. 2020;104:240-241.
    PubMed    


    January 2020
  10. HEALD-SARGENT TA, Forte E, Liu X, Thorp EB, et al
    New insights into the molecular mechanisms and immune control of cytomegalovirus reactivation.
    Transplantation. 2020 Jan 29. doi: 10.1097/TP.0000000000003138.
    PubMed     Abstract available


  11. DE PAULA MI, Bae S, Shaffer AA, Garonzik-Wang J, et al
    The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-Risk Kidney Transplant Recipients without Pharmacological Prophylaxis.
    Transplantation. 2020 Jan 16. doi: 10.1097/TP.0000000000003124.
    PubMed     Abstract available


    October 2019
  12. KLIMCZAK-TOMANIAK D, Roest S, Brugts JJ, Caliskan K, et al
    THE ASSOCIATION BETWEEN CYTOMEGALOVIRUS INFECTION AND CARDIAC ALLOGRAFT VASCULOPATHY IN THE ERA OF ANTIVIRAL VALGANCICLOVIR PROPHYLAXIS.
    Transplantation. 2019 Oct 21. doi: 10.1097/TP.0000000000003015.
    PubMed     Abstract available


    August 2019
  13. ENDO Y, Oshima G, Hibi T, Shinoda M, et al
    Achievement of Durable and Complete Remission of Graft-versus-host Disease After Liver Transplantation With Ruxolitinib: A Case Report.
    Transplantation. 2019 Aug 5. doi: 10.1097/TP.0000000000002904.
    PubMed    


  14. PAPPO A, Peled O, Berkovitch M, Bilavsky E, et al
    Efficacy and Safety of a Weight-based Dosing Regimen of Valganciclovir for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients.
    Transplantation. 2019;103:1730-1735.
    PubMed     Abstract available


  15. ALONSO-GUALLART P, Duran-Struuck R, Zitsman JS, Sameroff S, et al
    Impact of CMV reactivation, treatment approaches and immune reconstitution in a nonmyeloablative tolerance induction protocol in Cynomolgus macaques.
    Transplantation. 2019 Aug 1. doi: 10.1097/TP.0000000000002893.
    PubMed     Abstract available


  16. VEIT T, Munker D, Kauke T, Zoller M, et al
    Letermovir for difficult to treat cytomegalovirus infection in lung transplant recipients.
    Transplantation. 2019 Aug 1. doi: 10.1097/TP.0000000000002886.
    PubMed     Abstract available


    July 2019
  17. KUMAR D, Selzner N
    Cytomegalovirus: The "Troll of Transplantation" is now the "Troll of Tolerance".
    Transplantation. 2019 Jul 25. doi: 10.1097/TP.0000000000002894.
    PubMed    


    May 2019
  18. PHOOMPOUNG P, Ferreira VH, Tikkanen J, Husain S, et al
    Letermovir as Salvage Therapy for CMV Infection in Transplant Recipients.
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002785.
    PubMed     Abstract available


    April 2019
  19. FERNANDEZ-RUIZ M, Rodriguez-Goncer I, Ruiz-Merlo T, Parra P, et al
    Low 25-hydroxyvitamin D levels and the risk of late CMV infection after kidney transplantation: role for CMV-specific mediated immunity.
    Transplantation. 2019 Apr 22. doi: 10.1097/TP.0000000000002770.
    PubMed    


    March 2019
  20. GUNTHER BROCKMANN J, Butt A, AlHussaini HF, AlMana H, et al
    Protocol Duodenal Graft Biopsies Aid Pancreas Graft Surveillance.
    Transplantation. 2019;103:622-629.
    PubMed     Abstract available


    February 2019
  21. VAN DER VEER MAA, Nangrahary N, Hesselink DA, Erler NS, et al
    High Intra-Patient Variability in Tacrolimus Exposure Is Not Associated with Immune-Mediated Graft Injury after Liver Transplantation.
    Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002680.
    PubMed     Abstract available


  22. ASTOR BC, Djamali A, Mandelbrot DA, Parajuli S, et al
    The Association of 25-Hydroxyvitamin D Levels with Late Cytomegalovirus Infection in Kidney Transplant Recipients: the Wisconsin Allograft Recipient Database (WisARD).
    Transplantation. 2019 Feb 13. doi: 10.1097/TP.0000000000002672.
    PubMed     Abstract available


    November 2018
  23. YEO SJ, Kwon KT, Kim ES, Jung MK, et al
    Development of a predictive model using endoscopic features for gastric cytomegalovirus infection in renal transplant patients.
    Transplantation. 2018 Nov 30. doi: 10.1097/TP.0000000000002554.
    PubMed     Abstract available


  24. HARPUR CM, Stankovic S, Kanagarajah A, Widjaja JML, et al
    Enrichment of cytomegalovirus-induced NKG2C+ Natural Killer cells in the lung allograft.
    Transplantation. 2018 Nov 19. doi: 10.1097/TP.0000000000002545.
    PubMed     Abstract available


    September 2018
  25. WESTALL GP, Cristiano Y, Levvey BJ, Whitford H, et al
    A Randomized Study of Quantiferon-CMV-Directed Versus Fixed Duration Valganciclovir Prophylaxis to Reduce Late CMV Following Lung Transplantation.
    Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002454.
    PubMed     Abstract available


  26. CALABRESE DR, Chong T, Wang A, Singer JP, et al
    NKG2C natural killer cells in bronchoalveolar lavage are associated with cytomegalovirus viremia and poor outcomes in lung allograft recipients.
    Transplantation. 2018 Sep 11. doi: 10.1097/TP.0000000000002450.
    PubMed     Abstract available


    August 2018
  27. JARQUE M, Melilli E, Crespo E, Manonelles A, et al
    CMV-specific Cell-Mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at risk of Late-onset CMV Infection Regardless the Type of Induction Therapy.
    Transplantation. 2018 Aug 20. doi: 10.1097/TP.0000000000002421.
    PubMed     Abstract available


  28. KOTTON CN
    Migrating From Universal to Personalized Prevention: Predicting the Risk of Cytomegalovirus Infection after Organ Transplantation.
    Transplantation. 2018 Aug 20. doi: 10.1097/TP.0000000000002422.
    PubMed    


  29. MEESING A, Abraham RS, Razonable RR
    Clinical Correlation of Cytomegalovirus Infection with CMV-Specific CD8+ T Cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients.
    Transplantation. 2018 Aug 6. doi: 10.1097/TP.0000000000002396.
    PubMed     Abstract available


    July 2018
  30. FERREIRA VH, Kumar D, Humar A
    Deep Profiling of the CD8+ T cell Compartment identifies Activated cell subsets and Multifunctional Responses Associated with Control of Cytomegalovirus Viremia.
    Transplantation. 2018 Jul 18. doi: 10.1097/TP.0000000000002373.
    PubMed     Abstract available


    April 2018
  31. SANTOS CAQ, Brennan DC
    Cytomegalovirus: a Guide for the Perplexed.
    Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002203.
    PubMed    


    March 2018
  32. KOTTON CN, Kumar D, Caliendo AM, Huprikar S, et al
    The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.
    Transplantation. 2018 Mar 29. doi: 10.1097/TP.0000000000002191.
    PubMed     Abstract available


  33. JACOBSEN MC, Manunta MDI, Pincott ES, Fenton M, et al
    Specific Immunity to Cytomegalovirus in Pediatric Cardiac Transplantation.
    Transplantation. 2018 Mar 5. doi: 10.1097/TP.0000000000002157.
    PubMed     Abstract available


    January 2018
  34. CHAIYAPAK T, Borges K, Williams A, Banh T, et al
    Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients after Cessation of Antiviral Prophylaxis.
    Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002115.
    PubMed     Abstract available


    December 2017
  35. LIU AW, Jutivorakool K, Fisher CE, Rakita RM, et al
    Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002029.
    PubMed     Abstract available


    November 2017
  36. WITZKE O, Nitschke M, Bartels M, Wolters H, et al
    Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: Long-term results after 7 years of a randomized clinical trial.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002024.
    PubMed     Abstract available


    September 2017
  37. HO J, Schaub S, Wiebe C, Gao A, et al
    Urinary CXCL10 chemokine is associated with alloimmune and virus compartment-specific renal allograft inflammation.
    Transplantation. 2017 Sep 12. doi: 10.1097/TP.0000000000001931.
    PubMed     Abstract available


    August 2017
  38. LODDING IP, Schultz HH, Jensen JU, Kirkby N, et al
    Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001927.
    PubMed     Abstract available


    June 2017
  39. BALL S
    Aggregating Marginal Gains in Posttransplant CMV Risk Stratification.
    Transplantation. 2017 Jun 29. doi: 10.1097/TP.0000000000001869.
    PubMed    


  40. SCHACHTNER T, Stein M, Reinke P
    CMV-specific T Cell Monitoring Offers Superior Risk Stratification of CMV-seronegative Kidney Transplant Recipients of a CMV-seropositive Donor.
    Transplantation. 2017 Jun 7. doi: 10.1097/TP.0000000000001825.
    PubMed     Abstract available


    February 2017
  41. SANTOS AH JR, Casey MJ, Xuerong W, Womer KL, et al
    Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
    Transplantation. 2017;101:377-386.
    PubMed     Abstract available


  42. DURAN-STRUUCK R, Sondermeijer HP, Buhler L, Alonso-Guallart P, et al
    Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
    Transplantation. 2017;101:274-283.
    PubMed     Abstract available


    January 2017

  43. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation: Erratum.
    Transplantation. 2017;101:e40.
    PubMed    


    December 2016
  44. MICHAELS MG, Humar A
    Cytomegalovirus in the Pediatric Transplant Recipient: where are we now?
    Transplantation. 2016 Dec 31. doi: 10.1097/TP.0000000000001627.
    PubMed    


  45. ABATE D
    The First 90 Days: Temporary Effect of Alemtuzumab on CMV Immune Reconstitution.
    Transplantation. 2016.
    PubMed    


    November 2016
  46. GE S, Karasyov A, Sinha A, Petrosyan A, et al
    Cytomegalovirus Immunity after Alemtuzumab Induction in Desensitized Kidney Transplant Patients.
    Transplantation. 2016.
    PubMed     Abstract available


    October 2016
  47. NICASTRO E, Giovannozzi S, Stroppa P, Callegaro AP, et al
    Effectiveness of preemptive therapy for Cytomegalovirus disease in pediatric liver transplantation.
    Transplantation. 2016.
    PubMed     Abstract available


    August 2016
  48. FINE NM, Kushwaha SS
    RECENT ADVANCES IN MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR USE IN HEART AND LUNG TRANSPLANTATION.
    Transplantation. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: